Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 02, 2020

SELL
$47.45 - $62.95 $40,095 - $53,192
-845 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$46.85 - $61.05 $11,197 - $14,590
239 Added 39.44%
845 $50,000
Q3 2018

Nov 14, 2018

BUY
$42.88 - $53.7 $25,985 - $32,542
606 New
606 $31,000
Q1 2018

May 16, 2018

SELL
$44.08 - $55.05 $68,059 - $84,997
-1,544 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$45.56 - $59.57 $70,344 - $91,976
1,544
1,544 $78,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.1B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Balentine LLC Portfolio

Follow Balentine LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.